| The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report AV Chobanian, GL Bakris, HR Black, WC Cushman, LA Green, JL Izzo Jr, ... Jama 289 (19), 2560-2571, 2003 | 24715 | 2003 |
| Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure AV Chobanian, GL Bakris, HR Black, WC Cushman, LA Green, JL Izzo Jr, ... hypertension 42 (6), 1206-1252, 2003 | 17802 | 2003 |
| 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) PA James, S Oparil, BL Carter, WC Cushman, C Dennison-Himmelfarb, ... Jama 311 (5), 507-520, 2014 | 11314 | 2014 |
| Effects of intensive blood-pressure control in type 2 diabetes mellitus ACCORD Study Group New England Journal of Medicine 362 (17), 1575-1585, 2010 | 4317 | 2010 |
| Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for … DA Calhoun, D Jones, S Textor, DC Goff, TP Murphy, RD Toto, A White, ... Hypertension 51 (6), 1403-1419, 2008 | 3966 | 2008 |
| Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid … T Antihypertensive, ... Jama 288 (23), 2981-2997, 2002 | 3430 | 2002 |
| Alogliptin after acute coronary syndrome in patients with type 2 diabetes WB White, CP Cannon, SR Heller, SE Nissen, RM Bergenstal, GL Bakris, ... New England journal of medicine 369 (14), 1327-1335, 2013 | 3124 | 2013 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2358 | 2019 |
| Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial F Ismail-Beigi, T Craven, MA Banerji, J Basile, J Calles, RM Cohen, ... The Lancet 376 (9739), 419-430, 2010 | 1790 | 2010 |
| Single-Drug Therapy for Hypertension in Men--A Comparison of Six Antihypertensive Agents with Placebo BJ Materson, DJ Reda, WC Cushman, BM Massie, ED Freis, MS Kochar, ... New England Journal of Medicine 328 (13), 914-921, 1993 | 1584 | 1993 |
| Original Papers. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid‐lowering treatment to prevent heart attack … WC Cushman, CE Ford, JA Cutler, KL Margolis, BR Davis, RH Grimm, ... The Journal of Clinical Hypertension 4 (6), 393-404, 2002 | 1336 | 2002 |
| Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial JD Williamson, NM Pajewski, AP Auchus, RN Bryan, G Chelune, ... Jama 321 (6), 553-561, 2019 | 900 | 2019 |
| Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial F Zannad, CP Cannon, WC Cushman, GL Bakris, V Menon, AT Perez, ... The Lancet 385 (9982), 2067-2076, 2015 | 878 | 2015 |
| Diabetes and hypertension: the bad companions E Ferrannini, WC Cushman The Lancet 380 (9841), 601-610, 2012 | 765 | 2012 |
| Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT) BR Davis, JA Cutler, DJ Gordon, CD Furberg, JT Wright Jr, WC Cushman, ... American journal of hypertension 9 (4), 342-360, 1996 | 727 | 1996 |
| The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure National High Blood Pressure Education Program Arch intern med 157, 2413-2446, 1997 | 608 | 1997 |
| Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant … K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy, R Ramakrishnan, ... The Lancet 397 (10285), 1625-1636, 2021 | 561 | 2021 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 555 | 2019 |
| Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril JT Wright, JK Dunn, JA Cutler, BR Davis, WC Cushman, CE Ford, ... Jama 293 (13), 1595-1608, 2005 | 526 | 2005 |
| The role of diastolic blood pressure when treating isolated systolic hypertension GW Somes, M Pahor, RI Shorr, WC Cushman, WB Applegate Archives of internal medicine 159 (17), 2004-2009, 1999 | 524 | 1999 |
